6-7 November Ministry of Health, Youth, Sport and Voluntary Sector. Pierre Laroque Amphitheater
|
|
|
- Meagan Wilkinson
- 5 years ago
- Views:
Transcription
1 EUROPEAN WORKSHOP PUBLIC AWARENESS CAMPAIGNS ON THE PRUDENT USE OF ANTIBIOTICS 6-7 November 2008 Ministry of Health, Youth, Sport and Voluntary Sector Pierre Laroque Amphitheater 14, avenue Duquesne, Paris 07 SP Subway stations: Cambronne (line 6), Ecole Militaire (line 8), Ségur (line 10), Saint François- Xavier (line 13) (13/10/2008) 1
2 Thursday 6 November :00-13:30 WELCOME COFFEE 13:30-13:45 OFFICIAL OPENING Mrs Roselyne Bachelot-Narquin, Minister of Health, Youth, Sport and Voluntary Sector 13:45-14:15 EUROPEAN PERSPECTIVES ON THE FIGHT AGAINST ANTIBIOTIC RESISTANCE DG Health & Consumers, European Commission 14:15-14:30 RATIONALE FOR A EUROPEAN WORKSHOP ON PUBLIC AWARENESS CAMPAIGNS ON THE PRUDENT USE OF ANTIBIOTICS Pr Benoît Schlemmer, President of the French National Committee «Keep Antibiotics Working» 14:30-16:00 EXAMPLES OF NATIONAL AWARENESS CAMPAIGNS DIRECTED AT THE GENERAL PUBLIC AND GENERAL PRACTITIONERS Dr Inge C. Gyssens, Dutch Working Party on Antibiotic Policy (SWAB); Pr Milan Cizman, Slovenian Intersectoral Coordination Mechanism on Antibiotic Resistance 14:30-14:45 The French public campaigns «Antibiotics, it s not automatic» Mrs Geneviève Chapuis, French National Health Insurance Fund for Salaried Workers (CNAMTS) 14:45-15:00 How to increase awareness of the general public about prudent use of antibiotics in a smaller country: Sweden Pr Otto Cars, Swedish Strategic Programme Against Antibiotic Resistance (STRAMA) 2
3 15:00-15:15 Actions directed at general practitioners: France Dr Thierry Demerens, French National Health Insurance Fund for Salaried Workers (CNAMTS) 15:15-15:30 Actions directed at general practitioners: UK Dr Mark Ashworth, King's College, London, UK 15:30-16:00 Discussion 16:00-16:30 COFFEE BREAK 3
4 16:30-17:00 PUBLIC ANTIBIOTIC AWARENESS CAMPAIGNS IN EUROPE Dr Stephan Harbarth, Dr Benedikt Huttner, Geneva University Hospitals, Geneva, Switzerland 17:00-17:15 Discussion Dr Vlastimil Jindrák, Czech National Antibiotic Programme Coordinating Group; Dr José Campos, Instituto de Salud Carlos III, Working group on antibiotics 17:15-18:00 ROUND TABLE. NATIONAL AWARENESS CAMPAIGNS DIRECTED AT THE GENERAL PUBLIC AND GENERAL PRACTITIONERS: LESSONS AND STRATEGIC PRIORITIES Pr Benoît Schlemmer, French National Committee «Keep Antibiotics Working»; Pr Helen Giamarellou, Hellenic Task Force against Antimicrobial Resistance 17:15-17:20 Spain: Dr José Campos, Instituto de Salud Carlos III, Working group on antibiotics 17:20-17:25 Poland: Pr Waleria Hryniewicz, Polish National Programme of Antibiotic Protection 17:25-17:30 Czech Republic: Dr Vlastimil Jindrák, Czech National Antibiotic Programme Coordinating Group 17:30-17:35 United Kingdom: Pr Roger Finch, Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) 17:35-17:40 Greece: Pr Helen Giamarellou, Hellenic Task Force against Antimicrobial Resistance 17:40-17:45 Belgium: Pr Herman Goossens, Belgian Antibiotic Policy Coordinating Committee (BAPCOC) 4
5 17:45-18:15 Discussion 18:15-18:45 THE GET SMART CAMPAIGN: IMPROVING ANTIBIOTIC USE IN THE U.S. 18:15-18:30 Presentation Dr. Lauri A. Hicks, Director, Division of Bacterial Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta 18:30-18:45 Discussion 18:45 END OF FIRST DAY. 19:30 BUFFET DINNER AT UNESCO 5
6 Friday 7 November :00-8:30 WELCOME COFFEE 8:30-9:30 EVALUATION OF THE IMPACT ON ANTIBIOTIC PRESCRIPTIONS OF AWARENESS CAMPAIGNS Dr Anne Castot, French Medicine Drugs Agency (Afssaps) Pr Waleria Hryniewicz, Polish National Programme of Antibiotic Protection 8:30-8:45 Quality indicators for outpatient antibiotics prescribing Pr Jean Carlet, French National Authority for Health (HAS) 8:45-9:00 Studies to measure the awareness and attitudes of the public before the campaign: experience from Greece Pr Helen Giamarellou, Hellenic Task Force against Antimicrobial Resistance 9:00-9:15 How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, European Centre for Disease Prevention and Control (ECDC) 9:15-9:30 Discussion 6
7 9:30-10:30 ADJUNCT MEASURES AND OTHER POINTS THAT MUST BE TAKEN INTO ACCOUNT WHEN EVALUATING THE IMPACT OF AWARENESS CAMPAIGNS ON ANTIBIOTIC RESISTANCE Dr Jean-Claude Desenclos, National Institute for Public Health Surveillance (InVS), France; Dr Todor Kantardjiev, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria 9:30-9:45 The role of vaccination in the control of antibiotic resistance in pneumocci, French experience Dr Emmanuelle Varon, National Reference Center for S. pneumoniae, France, Dr Agnès Lepoutre, National Institute for Public Health Surveillance (InVS), France 9:45-10:00 Reducing disease and antibiotic use in one shot: the use of vaccines to prevent antibiotic resistance Dr. Lauri A. Hicks, Director, Division of Bacterial Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta 10:00-10:15 Changes in antibiotic resistance in bacteria from outpatients: selective antibiotic pressure or clonal spread Pr Hajo Grundmann, European Antimicrobial Resistance Surveillance System (EARSS) 10:15-10:30 Discussion 10:30-11:00 COFFEE BREAK 7
8 11:00-12:00 PUBLIC HEALTH IMPACT OF NATIONAL PROGRAMMES ON THE PRUDENT USE OF ANTIBIOTICS Pr Hajo Grundmann, European Antimicrobial Resistance Surveillance System (EARSS), The Netherlands; Dr. Kuulo Kutsar, Health Protection Inspectorate, Estonia 11:00-11:15 Do poor outcomes of outpatient bacterial infections increase with decreasing antibiotic consumption: French data Dr Bruno Coignard, National Institute for Public Health Surveillance (InVS), France; 11:15-11:30 Do poor outcomes of outpatient bacterial infections increase with decreasing antibiotic consumption: Swedish data 11:30-12:00 Discussion Dr Mats Erntell, Swedish Strategic Programme Against Antibiotic Resistance (STRAMA) 12:00-14:00 LUNCH AT THE FRENCH MILITARY ACADEMY 8
9 14:00-14:45 IMPACT OF AWARENESS CAMPAIGNS ON THE PREVALENCE OF ANTIBIOTIC RESISTANCE Pr Gérard Krause, Robert Koch Institute, Berlin, Germany; Dr Rolanda Valinteliene, Institute of Hygiene, Vilnius, Lithuania 14:00-14:15 Impact of the French national campaigns on antibiotic resistance in bacteria from outpatients Pr Vincent Jarlier, French National Observatory for Epidemiology of Bacterial Resistance to Antimicrobials (ONERBA) 14:15-14:30 National campaigns and their impact on antibiotic resistance: an European overview Dr Benedikt Huttner, Geneva University Hospitals, Geneva, Switzerland 14:30-14:45 Discussion 9
10 14:45-15:45 QUANTITATIVE AND QUALITATIVE OBJECTIVES OF THE CONSUMPTION OF ANTIBIOTICS IN COMMUNITY Pr Herman Goossens, Belgian Antibiotic Policy Coordinating Committee (BAPCOC); Pr Benoît Schlemmer, French National Committee «Keep Antibiotics Working» 14:45-15:00 Netherlands: should outpatients receive antibiotics more often? Dr Inge C. Gyssens, Dutch Working Party on Antibiotic Policy (SWAB) 15:00-15:15 Sweden: is it reasonable and possible to further lower antibiotic exposure of outpatients? 15:15-15:45 Discussion Dr Mats Erntell, Swedish Strategic Programme against Antibiotic Resistance (STRAMA) 15:45-16:00 CONCLUSION AND PERSPECTIVES Dr Dominique L. Monnet, European Centre for Disease Prevention and Control (ECDC), on behalf of chairpersons Pr Didier Houssin, Chief Medical Officer, French Ministry of Health 16:00 END OF WORKSHOP 10
How do people obtain antibiotics in European countries: an overview
How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points
What is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
Summary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)
Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group
Antibiotics and resistance in the WHO Regional Office for Europe Dr Nienke van de Sande On behalf of the AMR Working Group Strengthening the fight against antimicrobial Antimicrobial APRES resistance Symposium
Summary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
Stop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
Consumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
Antimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
Stratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
Quelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
Stratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
MRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
Antibiotic resistance: a geopolitical issue
REVIEW 10.1111/1469-0691.12767 Antibiotic resistance: a geopolitical issue J. Carlet 1, C. Pulcini 1,2,3 and L. J. V. Piddock 4,5 1) World Alliance Against Antimicrobial Resistance (WAAAR), Paris, 2) CHU
European Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
MRSA control strategies in Europekeeping up with epidemiology?
MRSA 15 years in Belgium MRSA control strategies in Europekeeping up with epidemiology? Marc J. Struelens, MD, PhD Senior Expert, Scientific Advice Unit European Centre for Disease Prevention and Control,
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
The challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
The evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
Perspectives. i s o l a t e s : t h e Fr e n c h e x p e r i e n c e. 4 EUROSURVEILLANCE Vol. 13 Issue November
Perspectives R e c e n t t r e n d s in a n t i m i c r o b i a l r e s i s ta n c e a m o n g S t r e p t o c o c c u s p n e u m o n i a e a n d S t a p h y lo c o c c u s a u r e u s i s o l a t e s
WHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
The European AMR Challenge - strategic views from the human perspective -
The European AMR Challenge - strategic views from the human perspective - World Health Organization Regional Office for Europe Dr Danilo Lo Fo Wong Senior Adviser on Antimicrobial Resistance Division of
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
AMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
NEWSLETTER 1 MARCH Produced by CSO-MOH IL
Produced by CSO-MOH IL Contact: The JPIAMR secretariat is hosted by the Swedish Research Council in Stockholm, Sweden and currently involves the following staff: Ana Beramendi Jenny Fernebro Anna Vallstedt
Antimicrobial Resistance, yes we care! The European Joint Action
Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action
W O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p
WHO strategic action plan on antibiotic resista ance in Europe Strengthening g surveillance Dr Danilo Lo Fo Wong Senior Adv viser AMR Backg ground AMR costs money, livelihoods and lives, and undermines
European poultry industry trends
European poultry industry trends November 5 th 2014, County Monaghan Dr. Aline Veauthier & Prof. Dr. H.-W. Windhorst (WING, University of Vechta) 1 Agenda The European Chicken Meat Market - The global
R e s e a rc h a r ti cl e s
R e s e a rc h a r ti cl e s E u r o p e a n A n t i b i o t i c A wa r e n e s s D ay, 2 0 0 8 t h e f i r s t E u r o p e - w i d e p u b l i c i n f o r m at i o n c a m pa i g n o n p r u d e n t a
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
Table Of Content. Outputs... 8
Table Of Content Establishment of Quality Assurances for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism Risk... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Swedish Institute
The threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe Dominique L. Monnet, Head of Disease Programme, Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Joint
Antibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
EFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
Antimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
THE DEVELOPMENT OF A RISK BASED MEAT INSPECTION SYSTEM SANCO / 4403 / 2000
FEDERATION OF VETERINARIANS OF EUROPE FVE/01/034 Final THE DEVELOPMENT OF A RISK BASED MEAT INSPECTION SYSTEM SANCO / 4403 / 2000 Members FVE COMMENTS Austria Belgium Croatia Cyprus Czech Republic Denmark
Council of the European Union Brussels, 13 June 2016 (OR. en)
Council of the European Union Brussels, 13 June 2016 (OR. en) 9952/16 SAN 241 AGRI 312 VETER 58 NOTE From: To: General Secretariat of the Council Council No. prev. doc.: 9485/16 SAN 220 AGRI 296 VETER
Seminar on communicable diseases prevention and control
Seminar on communicable diseases prevention and control INT MARKT 30085 organised in co-operation with Bulgarian National Center of Infectious and Parasitic Diseases and Directorate General Health and
EU Health Priorities. Jurate Svarcaite Secretary General PGEU
EU Health Priorities Jurate Svarcaite Secretary General PGEU Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia
COMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
Perspectives. i s o l a t e s : t h e Fr e n c h e x p e r i e n c e
Perspectives R e c e n t t r e n d s in a n t i m i c r o b i a l r e s i s ta n c e a m o n g S t r e p t o c o c c u s p n e u m o n i a e a n d S t a p h y lo c o c c u s a u r e u s i s o l a t e s
Table Of Content. D Final Report 'Primary Care Anti-infective agent prescribing for Common
Table Of Content Antibiotic Resistance and Prescribing in European Children... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associação de Saúde Infantil de Coimbra... 5 University of Tartu...
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR) Challenges on the global and regional levels Zsuzsanna Jakab WHO Regional Director for Europe 13 November support the WHO 2014, global action
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
Spa K 940 / 423. Abstract n K 940
K 940 / 423 Dr Jérôme ROBERT Bactériologie-Hygiène UPMC - Site Pitié-Salpêtrière 91 Bd de l hôpital - 75013 PARIS - France «jerome.robert@psl.aphp.fr» Dr Rémy GAUZIT Réanimation Ste Marthe Hôtel Dieu de
Measures relating to antimicrobial resistance (AMR)
Measures relating to antimicrobial resistance (AMR) Background information on antimicrobial resistance Antimicrobials are indispensable for the treatment of infectious diseases in both humans and animals.
Special Eurobarometer 478. Summary. Antimicrobial Resistance
Antimicrobial Resistance Survey requested by the European Commission, Directorate-General for Health and Food Safety and co-ordinated by the Directorate-General for Communication This document does not
REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT
1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved
Swedish strategies and methods to combat antibiotic resistance
Swedish strategies and methods to combat antibiotic resistance Stephan Stenmark MD, PhD, County Medical Officer Västerbotten County Council, Sweden Head of Department for communicable disease control and
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery
European Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
Antimicrobial use in humans
Antimicrobial use in humans Ann Versporten Prof. Herman Goossens OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals - 13 March 2013 - Ann.versporten@ua.ac.be Herman.goossens@uza.be
Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting
COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted
2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance
2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance Submitted by: Viet Nam Policy Forum on Strengthening Surveillance
German Antimicrobial Resistance Strategy DART 2020
German Antimicrobial Resistance Strategy DART 2020 AMR One Health Network meeting, 26 October 2018 Dr. Alexandra Clarici Division Infectious diseases, AMR, Hygiene, Vaccination Federal Ministry of Health,
Volume 13, Issue November 2008
Volume 13, Issue 46-13 November 2008 Editorials Turning the tide of antimicrobial resistance: Europe shows the way 2 by DL Monnet, KG Kristinsson Perspectives Recent trends in antimicrobial resistance
Campylobacter infections in EU/EEA and related AMR
Campylobacter infections in EU/EEA and related AMR Therese Westrell, ECDC EURL Campylobacter workshop, Uppsala, Sweden, 9 October 2018 Zoonoses Zoonotic infections in the EU, 2016 Campylobacteriosis (N
Promoting One Health : the international perspective OIE
Promoting One Health : the international perspective OIE Integrating Animal Health & Public Health: Antimicrobial Resistance SADC SPS Training Workshop (Animal Health) 29-31 January 2014 Gaborone, Botwana
2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels
2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October 2018 - Brussels Aurélien PEREZ, DG Health and Food Safety Political context European level e.g. September
The European road map against antimicrobial resistance
The European road map against antimicrobial resistance (a changing paradigm for drug discovery and development?) Paul M. Tulkens*, MD, PhD Cellular and Molecular Pharmacology Louvain Drug Research Institute
Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8
Table Of Content Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8 Conference... 8 Coordinator, Leader contact and partners... 9 Outputs... 10 Final report...
Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries
Antimicrobial Resistance Tackling the Burden in the European Union Briefing note for EU/EEA countries Antimicrobial Resistance Tackling the Burden in the European Union Contents Key messages 03 Use of
GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden
GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr Anders Tegnell, Ministry of Health and Social Affairs, Sweden One Health One World Increasing antibiotic resistance Antibiotic use and
Politique du bon usage des antibiotiques: état des lieux et perspectives en Europe
Politique du bon usage des antibiotiques: état des lieux et perspectives en Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
Antibiotic resistance is one of the biggest threats to global health, food security, and development today.
Antibiotic resistance Fact sheet Updated November 2017 Key facts Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Antibiotic resistance can affect
OIE PVS Pathway including Veterinary Education
OIE PVS Pathway including Veterinary Education OIE Global Conference on the Prudent Use of Antimicrobial Agents for Animals: International Solidarity to Fight against Antimicrobial Resistance Paris (France)
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
Antimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
Management of antimicrobial resistance in animals in Belgium : Measures in veterinary medicine in the One Health context
Management of antimicrobial resistance in animals in Belgium : Measures in veterinary medicine in the One Health context ECVPH - Liège, 4th October 2017 Dr. Jean-François HEYMANS DVM, Director Animal Health
WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
EU strategy to fight against Antimicrobial Resistance
EU strategy to fight against Antimicrobial Resistance OECD workshop on the Economics of Antimicrobial Use in the Livestock Sector and Development of Antimicrobial Resistance Paris, 12 October 2015 Martial
Global efforts to combat Antimicrobial Resistance
Global efforts to combat Antimicrobial Resistance Dr Danilo Lo Fo Wong Senior Adviser AMR On behalf of the WHO/Europe AMR Working Group The antibiotic era Many antibiotics/antimicrobials developed Many
April XVIII th. Nantes FRANCE. of the WVPA August AMVA.
April 2013 XVIII th Congress of the WVPA Nantes FRANCE 19 23 August 2013 wvpac2013@zoopole.asso.fr AMVA www.wvpac2013.org 1 Key points 1 000 delegates expected More than 50 countries represented regarding
NAP on AMR: Singapore
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
ESVAC meeting 3 March, 2017 EMA. Presented by Helen Jukes Co-chair RONAFA group, chair of the CVMP s Antimicrobials Working Party
Joint EMA/EFSA scientific opinion of the RONAFA advisory group on measures to reduce the need to use antimicrobial agents in animal husbandry in the EU ESVAC meeting 3 March, 2017 EMA Presented by Helen
MISSION REPORT. ECDC country visit to Spain to discuss antimicrobial resistance issues February
MISSION REPORT ECDC country visit to Spain to discuss antimicrobial resistance issues 15-19 February 2016 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Spain to discuss antimicrobial resistance
Antibiotic stewardship Implementing Strategies
2 nd Joint Conference on the Antimicrobial Resistance Action Plan (AMRAP) and the Strategy for the Control of Antimicrobial Resistance in Ireland (SARI) 1. Background Antibiotic stewardship Implementing
Belgian National Antibiotic Awareness Campaigns
Belgian National Antibiotic Awareness Campaigns Herman Goossens, Stijn De Corte, Samuel Coenen University of Antwerp and BAPCOC Joris Mateusen, Sarah Tulkens Absoluut Belgium Belgian National Antibiotic
OIE Platform on Animal Welfare for Europe
OIE Platform on Animal Welfare for Europe 26 th Conference of the OIE Regional Commission for Europe Bern, Switzerland, 22-26 September 2014 Dr. Stanislav RALCHEV OIE SRR Brussels Measure the progress
The Commission activities on AMR (focus on zoonotic issues)
The Commission activities on AMR (focus on zoonotic issues) R.M. Peran i Sala European Commission, DG SANCO London, 15.09.2011 1. DG SANCO and AMR High priority status given on AMR in DG SANCO EU Commission
COMBATING ANTIMICROBIAL RESISTANCE TIME FOR JOINT A CTION
6th EURL-AR Workshop 2012 Presentation of T HE DANISH EU- PRESIDENCY 2012 - CONFERENCE COMBATING ANTIMICROBIAL RESISTANCE TIME FOR JOINT A CTION Copenhagen 14-15 March 2012 and Relevant preliminary DRAFT
CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP PROGRAMME
CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP commissioned by the All Wales Medicines Strategy Group Tuesday 5 th Friday 8 th July 2016 Cardiff City Hall Cathays Park, Cardiff CF10 3ND PROGRAMME THE QUESTION
SEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS
SEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS Edita Alili-Idrizi, Msc Merita Dauti, Msc State University of Tetovo, Faculty of Medicine, Department of Pharmacy, Tetovo, R. of Macedonia
Special Eurobarometer 445. Summary
Survey requested by the European Commission, Directorate-General for Health and Food Safety and co-ordinated by the Directorate-General for Communication This document does not represent the point of view
International approach for veterinary medicinal products: OIE and Codex alimentarius
Dr Catherine Lambert OIE, AFSSA/ANMV Collaborating Centre for Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE c.lambert@anmv.afssa.fr International approach for veterinary medicinal
ECDC country visit to Luxembourg to discuss antimicrobial resistance issues
MISSION REPORT ECDC country visit to Luxembourg to discuss antimicrobial resistance issues 29 May-2 June 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Luxembourg to discuss antimicrobial
National Action Plan development support tools
National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan
GLOBAL CONFERENCE Global elimination of dog-mediated human rabies The Time Is Now
GLOBAL CONFERENCE Global elimination of dog-mediated human rabies The Time Is Now BACKGROUND Concept Note Rabies remains an under-reported and neglected zoonosis with a case fatality rate of almost 100%
rates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
MRSA found in British pig meat
MRSA found in British pig meat The first evidence that British-produced supermarket pig meat is contaminated by MRSA has been found in new research commissioned by The Alliance to Save Our Antibiotics
Swedish situation. Workshop, Riga, May 6, Birgitta Lytsy, infection control physician, Uppsala University hospital
Swedish situation Workshop, Riga, May 6, 2015 Birgitta Lytsy, infection control physician, Uppsala University hospital Olov Aspevall, physician, Swedish Public Health Agency, Stockholm Swedish situation
European strategic action plan on antibiotic resistance ( ) & Global action plan on AMR (2015)
European strategic action plan on antibiotic resistance (2011 2020) & Global action plan on AMR (2015) Dr Danilo Lo Fo Wong Programme Manager AMR WHO Regional Office for Europe Round table From discussion
Summary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)
Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA) Updated FAQ, 18 November 2014 Methicillin-resistant Staphylococcus aureus (MRSA) are bacteria which are resistant to certain
World Health Organization Emerging and other Communicable Diseases, Surveillance and Control
WHO/EMC/BAC/98.6 Antimicrobial Resistance Monitoring: Update of Activities 1997/1998 World Health Organization Emerging and other Communicable Diseases, Surveillance and Control This document has been
SALE OF REGULATED ANTIBIOTICS WITHOUT PRESCRIPTION - RESEARCH ON THE PHARMACISTS ATTITUDES AND PATTERNS OF ECONOMIC BEHAVIOR
TRAKIA JOURNAL OF SCIENCES Trakia Journal of Sciences, Vol. 10, No 4, pp 71-75, 2012 Copyright 2012 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7069 (print) ISSN 1313-3551 (online)